-transparent.png){kind=logo}
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma. 1988
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
Department of Clinical Oncology, Western General Hospital, Edinburgh.
A novel cytotoxic drug combination, PEEC, has been tested in the initial or salvage treatment of lymphomas. The PEEC combination alone is active in high grade or intermediate grade NHL with two complete and two partial remissions out of four patients so treated. When combined with standard CHOP therapy using an alternating regime, seven out of 11 patients obtained a complete remission and four partial remission. Ten patients were well, off treatment, beyond one year from presentation. The combination was less impressive, however, as salvage therapy with two partial responses in a heavily pre-treated group of nine patients.
Related Publications
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
December 1992,
Gan to kagaku ryoho. Cancer & chemotherapy,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
January 1986,
Scandinavian journal of haematology,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
June 2003,
Leukemia & lymphoma,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
March 1996,
Gan to kagaku ryoho. Cancer & chemotherapy,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
January 1992,
Cancer chemotherapy and pharmacology,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
May 2006,
Annals of oncology : official journal of the European Society for Medical Oncology,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
October 1995,
European journal of haematology,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
January 1990,
Acta oncologica (Stockholm, Sweden),
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
August 2004,
Leukemia & lymphoma,
R C Leonard, and
H H Lucraft, and
S J Proctor, and
N C Allan, and
A A Dawson, and
R C Leonard, and
H H Lucraft, and
J B McGillivray, and
A C Parker, and
R J Prescott
January 1991,
Hematological oncology,
